Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification

Analytical Cellular Pathology

Volumn 33, Issue 1, 2010, Pages 37-54

  Klink, Barbara ^a   Schlingelhof, Ben ^a   Klink, Martin ^a,c   Stout Weider, Karen ^a,d   Patt, Stephan ^b   Schrock, Evelin ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c DEUTSCHER WETTERDIENST   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CGH; GBMO; genetic subclassification; genetics; Glioblastoma; Interphase FISH; oligodendroglial component

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; GLIOBLASTOMA; HUMAN; INTERPHASE; MALE; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; BRAIN TUMOR; CLASSIFICATION; GENETICS; IMAGE PROCESSING; MIDDLE AGED; PATHOLOGY; THREE DIMENSIONAL IMAGING;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; OLIGODENDROGLIOMA;

EID: 79952277565     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.1155/2010/279317     Document Type: Article

References (59)

1. N. Aldosari, R.N. Wiltshire, A. Dutra, E. Schrock, R.E. McLendon, H.S. Friedman, D.D. Bigner and S.H. Bigner, Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft, Neuro Oncol. 4 (2002), 75-85. (Pubitemid 34285061)
2. S.H. Bigner, M.R. Matthews, B.K. Rasheed, R.N. Wiltshire, H.S. Friedman, A.H. Friedman, T.T. Stenzel, D.M. Dawes, R.E. McLendon and D.D. Bigner, Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization, Am. J. Pathol. 155 (1999), 375-386. (Pubitemid 29370388)
3. S.H. Bigner and E. Schrock, Molecular cytogenetics of brain tumors, J. Neuropathol. Exp. Neurol. 56 (1997), 1173-1181. (Pubitemid 27492773)
4. J.E. Bromberg and M.J. van den Bent, Oligodendrogliomas: molecular biology and treatment, Oncologist 14 (2009), 155-163.
5. G. Cairncross, B. Berkey, E. Shaw, R. Jenkins, B. Scheithauer, D. Brachman, J. Buckner, K. Fink, L. Souhami, N. Laperierre, M. Mehta and W. Curran, Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402, J. Clin. Oncol. 24 (2006), 2707-2714. (Pubitemid 46630566)
6. J.G. Cairncross, K. Ueki,M.C. Zlatescu, D.K. Lisle, D.M. Finkelstein, R.R. Hammond, J.S. Silver, P.C. Stark, D.R. Macdonald, Y. Ino, D.A. Ramsay and D.N. Louis, Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas, J. Natl. Cancer Inst. 90 (1998), 1473-1479. (Pubitemid 28482012)
7. S.W. Coons, P.C. Johnson, B.W. Scheithauer, A.J. Yates and D.K. Pearl, Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas, Cancer 79 (1997), 1381-1393. (Pubitemid 27143246)
8. C. Daumas-Duport, B. Scheithauer, J. O'Fallon and P. Kelly, Grading of astrocytomas. A simple and reproducible method, Cancer 62 (1988), 2152-2165. (Pubitemid 18261854)
9. C. Decaestecker, I. Camby, L. Gordower, O. Dewitte, P. Cras, J.J. Martin, J.L. Pasteels, P.V. Ham, J. Brotchi, R. Kiss and I. Salmon, Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy, J. Neuropathol. Exp. Neurol. 57 (1998), 791-802. (Pubitemid 28378156)
10. Z.-Q. Dong, J.C.-S. Pang, C.Y.-K. Tong, L.-F. Zhou and H.-K. Ng, Clonality of oligoastrocytomas, Hum. Pathol. 33 (2002), 528-535. (Pubitemid 34747873)
11. K.B. Fallon, C.A. Palmer, K.A. Roth, L.B. Nabors, W. Wang, M. Carpenter, R. Banerjee, P. Forsyth, K. Rich and A. Perry, Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas, J. Neuropathol. Exp. Neurol. 63 (2004), 314-322. (Pubitemid 38429028)
12. J. Felsberg, A. Erkwoh, M.C. Sabel, L. Kirsch, R. Fimmers, B. Blaschke, U. Schlegel, J. Schramm, O.D. Wiestler and G. Reifenberger, Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival, Brain Pathol. 14 (2004), 121-130. (Pubitemid 38656383)
13. C.E. Fuller, R.E. Schmidt, K.A. Roth, P.C. Burger, B.W. Scheithauer, R. Banerjee, K. Trinkaus, R. Lytle and A. Perry, Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features, J. Neuropathol. Exp. Neurol. 62 (2003), 1118-1128. (Pubitemid 37413823)
14. C.A. Griffin, P. Burger, L. Morsberger, R. Yonescu, S. Swierczynski, J.D. Weingart and K.M. Murphy, Identification of der(1; 19)(q10; p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss, J. Neuropathol. Exp. Neurol. 65 (2006), 988-994. (Pubitemid 44521799)
15. J. He, K.Mokhtari, M. Sanson, Y. Marie,M. Kujas, S. Huguet, P. Leuraud, L. Capelle, J.Y. Delattre, J. Poirier and K. Hoang-Xuan, Glioblastomas with an oligodendroglial component: a pathological and molecular study, J. Neuropathol. Exp. Neurol. 60 (2001), 863-871. (Pubitemid 32880594)
16. D.A. Hilton, M. Penney, L. Pobereskin, H. Sanders and S. Love, Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival, Histopathology 44 (2004), 555-560. (Pubitemid 38845101)
17. T. Homma, T. Fukushima, S. Vaccarella, Y. Yonekawa, P.L.D. Patre, S. Franceschi and H. Ohgaki, Correlation among pathology, genotype, and patient outcomes in glioblastoma, J. Neuropathol. Exp. Neurol. 65 (2006), 846-854. (Pubitemid 44371230)
18. K. Ichimura, A.P. Vogazianou, L. Liu, D.M. Pearson, L.M. Backlund, K. Plant, K. Baird, C.F. Langford, S.G. Gregory and V.P. Collins, 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas, Oncogene 27 (2008), 2097-2108. (Pubitemid 351442746)
19. A. Idbaih, Y. Marie, G. Pierron, C. Brennetot, K. Hoang-Xuan, M. Kujas, K. Mokhtari, M. Sanson, J. Lejeune, A. Aurias, O. Delattre and J.Y. Delattre, Two types of chromosome 1p losses with opposite significance in gliomas, Ann. Neurol. 58 (2005), 483-487. (Pubitemid 41266639)
20. R.B. Jenkins, H. Blair, K.V. Ballman, C. Giannini, R.M. Arusell, M. Law, H. Flynn, S. Passe, S. Felten, P.D. Brown, E.G. Shaw and J.C. Buckner, A t(1; 19)(q10; p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma, Cancer Res. 66 (2006), 9852-9861. (Pubitemid 44672036)
21. J.W. Jeuken, S.H. Sprenger, R.H. Boerman, A. von Deimling, H.L. Teepen, J.J. van Overbeeke and P. Wesseling, Subtyping of oligo-astrocytic tumours by comparative genomic hybridization, J. Pathol. 194 (2001), 81-87.
22. P. Kleihues, P.C. Burger, K.D. Aldape, D.J. Brat, W. Biernat, D.D. Bigner, Y. Nakazato, K.H. Plate, F. Giangaspero, A. von Deimling, H. Ohgaki and W.K. Cavenee, Glioblastoma, in: WHO Classification of Tumours of the Central Nervous System, D.N. Louis, H. Ohgaki, O.D. Wiestler and W.K. Cavenee, eds, International Agency for Research on Cancer (IARC) Press, Lyon, 2007, pp. 33-49.
23. P. Kleihues and W.K. Cavenee, Pathology and Genetics of Tumours of the Nervous System, World Health Organization Classification of Tumours, International Agency for Research on Cancer (IARC) Press, Lyon, 2000.
24. C.A. Klein, O. Schmidt-Kittler, J.A. Schardt, K. Pantel, M.R. Speicher and G. Riethmüller, Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells, Proc. Natl. Acad. Sci. USA 96 (1999), 4494-4499. (Pubitemid 29190364)
25. A. Korshunov, R. Sycheva and A. Golanov, The prognostic relevance of molecular alterations in glioblastomas for patients age 〈50 years, Cancer 104 (2005), 825-832. (Pubitemid 41113684)
26. R. Koschny, T. Koschny, U.G. Froster,W. Krupp and M.A. Zuber, Comparative genomic hybridization in glioma: a metaanalysis of 509 cases, Cancer Genet. Cytogenet. 135 (2002), 147-159. (Pubitemid 34786766)
27. J.A. Kraus, J. Koopmann, P. Kaskel, D. Maintz, S. Brandner, J. Schramm, D.N. Louis, O.D. Wiestler and A. von Deimling, Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma, J. Neuropathol. Exp. Neurol. 54 (1995), 91-95.
28. J.A. Kraus, K. Lamszus, N. Glesmann, M. Beck, M. Wolter, M. Sabel, D. Krex, T. Klockgether, G. Reifenberger and U. Schlegel, Molecular genetic alterations in glioblastomas with oligodendroglial component, Acta Neuropathol. (Berlin) 101 (2001), 311-320. (Pubitemid 32372420)
29. C. Lengauer, I. Dunham, T. Featherstone and T. Cremer, Generation of alphoid DNA probes for fluorescence in situ hybridization (FISH) using the polymerase chain reaction, Methods Mol. Biol. 33 (1994), 51-61.
30. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer and P. Kleihues, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol. 114 (2007), 97-109. (Pubitemid 47103521)
31. C.R. Miller and A. Perry, Glioblastoma, Arch. Pathol. Lab. Med. 131 (2007), 397-406.
32. A. Misra, M. Pellarin, J. Nigro, I. Smirnov, D. Moore, K.R. Lamborn, D. Pinkel, D.G. Albertson and B.G. Feuerstein, Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma, Clin. Cancer Res. 11 (2005), 2907-2918. (Pubitemid 40525192)
33. T. Nagasaka, M. Gunji, N. Hosokai, K. Hayashi, H. Ikeda, M. Ito and S. Inao, FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma, Brain Tumor Pathol. 24 (2007), 1-5. (Pubitemid 46836348)
34. M. Nakamura, F. Yang, H. Fujisawa, Y. Yonekawa, P. Kleihues and H. Ohgaki, Loss of heterozygosity on chromosome 19 in secondary glioblastomas, J. Neuropathol. Exp. Neurol. 59 (2000), 539-543. (Pubitemid 30368313)
35. Y. Nakazato, K.H. Plate, F. Giangaspero, A. von Deimling, H. Ohgaki and W.K. Cavenee, Glioblastoma, in: WHO Classification of Tumours of the Nervous System, D.N. Louis, H. Ohgaki, O.D.Wiestler and W.K. Cavenee, eds, IARC, Lyon, 2007, pp. 33-49.
36. T.C.G.A.R. Network, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature 455 (2008), 1061-1068.
37. T. Nishizaki, S. Ozaki, K. Harada, H. Ito, H. Arai, T. Beppu and K. Sasaki, Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization, Genes Chromosomes Cancer 21 (1998), 340-346. (Pubitemid 28165042)
38. H. Ohgaki and P. Kleihues, Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas, J. Neuropathol. Exp. Neurol. 64 (2005), 479-489. (Pubitemid 40781150)
39. H. Ohgaki and P. Kleihues, Genetic pathways to primary and secondary glioblastoma, Am. J. Pathol. 170 (2007), 1445-1453. (Pubitemid 47339290)
40. S. Patt, H. Gries, M. Giraldo, J. Cervos-Navarro, H. Martin, W. Jänisch and J. Brockmöller, p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas, Hum. Pathol. 27 (1996), 586-589. (Pubitemid 26187283)
41. W. Paulus and J. Peiffer, Intratumoral histologic heterogeneity of gliomas. A quantitative study, Cancer 64 (1989), 442-447. (Pubitemid 19180407)
42. L.W. Pinto, M.B. Araujo, A.L. Vettore, L. Wernersbach, A.C. Leite, L.M. Chimelli and F.A. Soares, Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis, Virchows Arch. 452 (2008), 481-490.
43. M. Qu, T. Olofsson, S. Sigurdardottir, C. You, H. Kalimo, M. Nister, A. Smits and Z.P. Ren, Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas, Acta Neuropathol. 113 (2007), 129-136. (Pubitemid 46158146)
44. K.S. Reddy, Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas, Cancer Genet. Cytogenet. 184 (2008), 77-86. (Pubitemid 351915763)
45. G. Reifenberger and D.N. Louis, Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology, J. Neuropathol. Exp. Neurol. 62 (2003), 111-126. (Pubitemid 36176946)
46. M. Salvati, A.I. Formichella, A. D'Elia, C. Brogna, A. Frati, F. Giangaspero, R. Delfini and A. Santoro, Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases, J. Neurooncol. 94 (2009), 129-134.
47. M.C. Schmidt, S. Antweiler, N. Urban, W. Mueller, A. Kuklik, B. Meyer-Puttlitz, O.D. Wiestler, D.N. Louis, R. Fimmers and A. von Deimling, Impact of genotype and morphology on the prognosis of glioblastoma, J. Neuropathol. Exp. Neurol. 61 (2002), 321-328. (Pubitemid 34266783)
48. E. Schrock, C. Blume, M.C. Meffert, S. du Manoir,W. Bersch, M. Kiessling, T. Lozanowa, G. Thiel, R. Witkowski, T. Ried and T. Cremer, Recurrent gain of chromosome arm 7q in lowgrade astrocytic tumors studied by comparative genomic hybridization, Genes Chromosomes Cancer 15 (1996), 199-205. (Pubitemid 26115928)
49. E. Schrock, G. Thiel, T. Lozanova, S. du Manoir, M.C. Meffert, A. Jauch, M.R. Speicher, P. Nürnberg, S. Vogel and W. Jänisch, Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses, Am. J. Pathol. 144 (1994), 1203-1218. (Pubitemid 24172083)
50. J.S. Smith, A. Perry, T.J. Borell, H.K. Lee, J. O'Fallon, S.M. Hosek, D. Kimmel, A. Yates, P.C. Burger, B.W. Scheithauer and R.B. Jenkins, Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas, J. Clin. Oncol. 18 (2000), 636-645. (Pubitemid 30078545)
51. B. Tews, J. Felsberg, C. Hartmann, A. Kunitz, M. Hahn, G. Toedt, K. Neben, L. Hummerich, A. von Deimling, G. Reifenberger and P. Lichter, Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling, Int. J. Cancer 119 (2006), 792-800. (Pubitemid 44051441)
52. D. Trost, M. Ehrler, R. Fimmers, J. Felsberg, M.C. Sabel, L. Kirsch, J. Schramm, O.D. Wiestler, G. Reifenberger and R.G. Weber, Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors, Int. J. Cancer 120 (2007), 2368-2376. (Pubitemid 46642123)
53. K. Ueki, R. Nishikawa, Y. Nakazato, T. Hirose, J. Hirato, N. Funada, T. Fujimaki, S. Hojo, O. Kubo, T. Ide, M. Usui, C. Ochiai, S. Ito, H. Takahashi, A. Mukasa, A. Asai and T. Kirino, Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors, Clin. Cancer Res. 8 (2002), 196-201. (Pubitemid 34101478)
54. M.J. van den Bent, A.F. Carpentier, A.A. Brandes, M. Sanson, M.J.B. Taphoorn, H.J.J.A. Bernsen, M. Frenay, C.C. Tijssen, W. Grisold, L. Sipos, H. Haaxma-Reiche, J.M. Kros, M.C.M. van Kouwenhoven, C.J. Vecht, A. Allgeier, D. Lacombe and T. Gorlia, Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial, J. Clin. Oncol. 24 (2006), 2715-2722. (Pubitemid 46630567)
55. A. von Deimling, D.N. Louis, K. von Ammon, I. Petersen, T. Hoell, R.Y. Chung, R.L. Martuza, D.A. Schoenfeld, M.G. Ya̧sargil and O.D. Wiestler, Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme, J. Neurosurg. 77 (1992), 295-301.
56. C. Walker, D.G. du Plessis, K.A. Joyce, Y. Machell, J. Thomson-Hehir, S.A.A. Haddad, J.C. Broome and P.C. Warnke, Phenotype versus genotype in gliomas displaying inter-or intratumoral histological heterogeneity, Clin. Cancer Res. 9 (2003), 4841-4851. (Pubitemid 37323288)
57. R.G. Weber, M. Sabel, J. Reifenberger, C. Sommer, J. Oberstrass, G. Reifenberger, M. Kiessling and T. Cremer, Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization, Oncogene 13 (1996), 983-994. (Pubitemid 26329085)
58. P.H. Wessels, A. Twijnstra, A.G.H. Kessels, B. Krijne-Kubat, P.H. Theunissen, M.I.J. Ummelen, F.C.S. Ramaekers and A.H. Hopman, Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2, Genes Chromosomes Cancer 33 (2002), 279-284. (Pubitemid 34130934)
59. E.C. Wooten, D. Fults, R. Duggirala, K. Williams, A.P. Kyritsis, M.L. Bondy, V.A. Levin and P. O'Connell, A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution, Neuro Oncol. 1 (1999), 169-176.